| Abstract | Redirected Optimized Cell Killing (ROCK®): A novel multispecific antibody platform for innate immune cell engagement to fight cancer |
| Session | Session 7 – NK cell Immunotherapy and Immunomodulation |
| Date and Time | Wednesday, October 2, 2019, 15:00 – 17:00 pm (CET) |
Affimed Publications & Posters
| Abstract | The CD30/CD16A innate cell engager AFM13 elicits polyfunctional NK cell responses effectively triggering memory-like (ML) NK cells against CD30+ targets |
| Session | Session 7 – NK cell Immunotherapy and Immunomodulation |
| Date and Time | Wednesday, October 2, 2019, 15:00 – 17:00 pm (CET) |
Affimed is proud to sponsor 10 travel grants for young researchers as part of its platinum sponsorship of NK2019.